Related Experiment Video
Updated: Jul 6, 2026

Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures
Published on: July 27, 2022
RAGE and RAGE ligands in cancer
Craig D Logsdon1, Maren K Fuentes, Emina H Huang
1Department of Cancer Biology, The University of Texas. Anderson Cancer Center, Unit 953, 1515 Holcombe Blvd., Houston, Texas 77030, USA. clogsdon@mdanderson.org
The receptor for advanced glycation end-products (RAGE) and its ligands promote cancer progression, metastasis, and chemoresistance. Targeting the RAGE-ligand axis offers a promising therapeutic strategy for various cancers.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The receptor for advanced glycation end-products (RAGE) is implicated in diseases like diabetes, arthritis, and Alzheimer's.
- Emerging evidence highlights RAGE's significant role in cancer development and progression.
Purpose of the Study:
- To review the role of the RAGE-ligand axis in cancer.
- To explore the therapeutic potential of targeting this axis in cancer treatment.
Main Methods:
- Literature review of studies investigating RAGE and its ligands in cancer.
- Analysis of RAGE ligand interactions with cancer cells and the tumor microenvironment.
Main Results:
- RAGE ligands (S100/calgranulins, HMGB1) secreted by cancer cells promote proliferation, invasion, chemoresistance, and metastasis.
- RAGE ligands influence tumor microenvironment cells, fostering fibrosis, inflammation, and angiogenesis.
- The RAGE-ligand axis drives cancer-promoting effects, though ligands may have other functions.
Conclusions:
- The RAGE-ligand axis is a critical factor in cancer progression and metastasis.
- Targeting the RAGE-ligand interaction presents a viable therapeutic strategy for cancer intervention.
Related Concept Videos
Mitogens and the Cell Cycle
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Selectins
